JP2022523196A5 - - Google Patents

Info

Publication number
JP2022523196A5
JP2022523196A5 JP2021549470A JP2021549470A JP2022523196A5 JP 2022523196 A5 JP2022523196 A5 JP 2022523196A5 JP 2021549470 A JP2021549470 A JP 2021549470A JP 2021549470 A JP2021549470 A JP 2021549470A JP 2022523196 A5 JP2022523196 A5 JP 2022523196A5
Authority
JP
Japan
Prior art keywords
crystalline
triazaspiro
decane
benzyl
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2021549470A
Other languages
English (en)
Japanese (ja)
Other versions
JP2022523196A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2020/019305 external-priority patent/WO2020172584A1/en
Publication of JP2022523196A publication Critical patent/JP2022523196A/ja
Publication of JP2022523196A5 publication Critical patent/JP2022523196A5/ja
Priority to JP2024005868A priority Critical patent/JP2024054139A/ja
Pending legal-status Critical Current

Links

JP2021549470A 2019-02-21 2020-02-21 Flna結合化合物及びその塩酸塩の固体多形 Pending JP2022523196A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2024005868A JP2024054139A (ja) 2019-02-21 2024-01-18 Flna結合化合物及びその塩酸塩の固体多形

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201962808609P 2019-02-21 2019-02-21
US62/808,609 2019-02-21
PCT/US2020/019305 WO2020172584A1 (en) 2019-02-21 2020-02-21 Solid polymorphs of a flna-binding compound and its hydrochloride salts

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2024005868A Division JP2024054139A (ja) 2019-02-21 2024-01-18 Flna結合化合物及びその塩酸塩の固体多形

Publications (2)

Publication Number Publication Date
JP2022523196A JP2022523196A (ja) 2022-04-21
JP2022523196A5 true JP2022523196A5 (https=) 2023-02-07

Family

ID=72141575

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2021549470A Pending JP2022523196A (ja) 2019-02-21 2020-02-21 Flna結合化合物及びその塩酸塩の固体多形
JP2024005868A Pending JP2024054139A (ja) 2019-02-21 2024-01-18 Flna結合化合物及びその塩酸塩の固体多形

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2024005868A Pending JP2024054139A (ja) 2019-02-21 2024-01-18 Flna結合化合物及びその塩酸塩の固体多形

Country Status (10)

Country Link
US (4) US11370791B2 (https=)
EP (1) EP3927707A4 (https=)
JP (2) JP2022523196A (https=)
KR (1) KR20210135530A (https=)
CN (2) CN114072406B (https=)
AU (1) AU2020224678B2 (https=)
BR (1) BR112021016622A2 (https=)
CA (1) CA3131146A1 (https=)
IL (1) IL285763A (https=)
WO (1) WO2020172584A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2020172584A1 (en) 2019-02-21 2020-08-27 Pain Therapeutics, Inc. Solid polymorphs of a flna-binding compound and its hydrochloride salts
US20220233512A1 (en) * 2020-11-03 2022-07-28 Cassava Sciences, Inc. Inhibiting an immune response mediated by one or more of tlr2, rage, ccr5, cxcr4 and cd4

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102004014304A1 (de) 2004-03-22 2005-10-06 Grünenthal GmbH Substituierte 1,4,8- Triazaspiro[4,5]decan-2-on-Verbindungen
US8653068B2 (en) * 2009-10-30 2014-02-18 Pain Therapeutics, Inc. Filamin A binding anti-inflammatory and analgesic
US9340558B2 (en) * 2007-11-02 2016-05-17 Pain Therapeutics Inc. Filamin a binding anti-inflammatory and analgesic
US8614324B2 (en) * 2008-10-31 2013-12-24 Pain Therapeutics, Inc. Filamin A binding anti-inflammatory and analgesic
WO2010051497A1 (en) * 2008-10-31 2010-05-06 Pain Therapeutics, Inc. Filamin a binding anti-inflammatory and analgesic
EP2549873A1 (en) * 2010-03-25 2013-01-30 Merck Sharp & Dohme Corp. Novel spiro imidazolones as glucagon receptor antagonists, compositions, and methods for their use
WO2014012054A1 (en) 2012-07-13 2014-01-16 Pain Therapeutics, Inc. Alzheimer's disease assay in a living patent
EP2882428B1 (en) * 2012-07-13 2019-01-16 Pain Therapeutics, Inc. A method of inhibiting tau phosphorylation
US9433604B2 (en) * 2013-10-08 2016-09-06 Pain Therapeutics Inc. Method for inhibiting growth of cancer cells
WO2020172584A1 (en) 2019-02-21 2020-08-27 Pain Therapeutics, Inc. Solid polymorphs of a flna-binding compound and its hydrochloride salts

Similar Documents

Publication Publication Date Title
JP2023002516A5 (https=)
JP2024516371A5 (https=)
JP2018024682A5 (https=)
JP2005533860A5 (https=)
HRP20170634T4 (hr) Kristalni oblik od 4-metil-n-[3-(4-metil-imidazol-1-il)-5-trifluorometil-fenil]-3-(4-piridin-3-il-pirimidin-2-ilamino)-benzamida
JP2006526031A5 (https=)
JP2021191784A5 (https=)
JP2010530897A5 (https=)
JP2022523196A5 (https=)
JP2010501478A5 (https=)
JP2010533203A5 (https=)
JP2020512316A5 (https=)
JP2018035160A5 (https=)
JP2023036708A5 (https=)
JP2007532560A5 (https=)
JP2019532919A5 (https=)
JP2012507535A5 (https=)
RS52663B2 (sr) Nova kristalna forma tiotropijum bromida i proces njene pripreme
JP2009521414A5 (https=)
JP2010520214A5 (https=)
JP2007537301A5 (https=)
JP2012526766A5 (https=)
JP2008516004A5 (https=)
JP2008513510A5 (https=)
JP2010507590A5 (https=)